GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » DexCom Inc (XTER:DC4) » Definitions » Ending Cash Position

DexCom (XTER:DC4) Ending Cash Position : €784 Mil (As of Mar. 2024)


View and export this data going back to 1990. Start your Free Trial

What is DexCom Ending Cash Position?

DexCom's Ending Cash Position for the quarter that ended in Mar. 2024 was €784 Mil.

DexCom's quarterly Ending Cash Position declined from Sep. 2023 (€604 Mil) to Dec. 2023 (€520 Mil) but then increased from Dec. 2023 (€520 Mil) to Mar. 2024 (€784 Mil).

DexCom's annual Ending Cash Position declined from Dec. 2021 (€932 Mil) to Dec. 2022 (€607 Mil) and declined from Dec. 2022 (€607 Mil) to Dec. 2023 (€520 Mil).


DexCom Ending Cash Position Historical Data

The historical data trend for DexCom's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexCom Ending Cash Position Chart

DexCom Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 401.76 672.56 932.44 607.28 520.40

DexCom Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 583.10 1,103.91 604.18 520.40 784.21

DexCom Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

DexCom's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=589.906+-69.509
=520

DexCom's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=522.1+262.108
=784


DexCom Ending Cash Position Related Terms

Thank you for viewing the detailed overview of DexCom's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


DexCom (XTER:DC4) Business Description

Traded in Other Exchanges
Address
6340 Sequence Drive, San Diego, CA, USA, 92121
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

DexCom (XTER:DC4) Headlines

No Headlines